Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
K22030 Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist(K22030-10.2) 10.2 Journal of Nanobiotechnology
K22030 Notch signaling activation contributes to paclitaxel-induced neuropathic pain via activation of A1 astrocytes(K22030-3.064) 3.064 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
K22030 The Prostaglandin E2 Receptor EP4 Promotes Vascular Neointimal Hyperplasia through Translational Control of Tenascin C via the cAMP/PKA/mTORC1/rpS6 Pathway(K22030-7.666) 7.666 Cells
K22030 miRNA‐194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1(K22030-2.231) 2.231 FEBS Open Bio
K22030 MiR-1b up-regulation inhibits rat neuron proliferation and regeneration yet promotes apoptosis via targeting KLF7(K22030-1.278) 1.278 Folia Neuropathol
K22030 Nox2 contributes to reactive oxygen species-induced redox imbalance in cancer-induced bone pain(K22030-3.375) 3.375 Am J Transl Res
K22030 Berberine modulates Keratin 17 to inhibit cervical cancer cell viability and metastasis(K22030-1.466) 1.466 Journal of Receptors and Signal
K22030 The spinal α7-nicotinic acetylcholine receptor contributes to the maintenance of cancer-induced bone pain(K22030-2.386) 2.386 J Pain Res
K22030 NGF-Induced Nav1. 7 Upregulation Contributes to Chronic Post-surgical Pain by Activating SGK1-Dependent Nedd4-2 Phosphorylation(K22030-4.5) 4.5 Mol Neurobiol
K22030 The Spinal α7-Nicotinic Acetylcholine Receptor Contributes to the Maintenance of Cancer-Induced Bone Pain(K22030-3.3) 3.3 Journal of Pain Research